Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Schisandrin
Cat. No.:
OB0125LY-091
Appearance:
Solid
Purity:
99.3%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Schisandrin is a natural product with anti-asthmatic, anti-cancer, and anti-inflammatory effects.
Synonym:
7432-28-2; Wuweizi alcohol-A; Wuweizichun-A; Schizandrol-A; Schizandrol; (+)-Schizandrin; (6S,7S,12aR)-1,2,3,10,11,12-Hexamethoxy-6,7-dimethyl-5,6,7,8-tetrahydrodibenzo[a,c][8]annulen-6-ol; (6S,7S)-1,2,3,10,11,12-Hexamethoxy-6,7-dimethyl-5,6,7,8-tetrahydrodibenzo[a,c][8]annulen-6-ol; (9S,10S)-3,4,5,14,15,16-Hexamethoxy-9,10-dimethyltricyclo[10.4.0.02,7]hexadeca-1 (16),2,4,6,12,14-hexaen-9-ol; Dibenzo (a,c)cycloocten-6-ol, 5,6,7,8-tetrahydro-6,7-dimethyl-1,2 3,10,11,12-hexamethoxy-, stereoisomer; Dibenzo[a,c]cycloocten-6-ol, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, (6S,7S)-
CAS No.:
7432-28-2
Compound CID:
3001664
Formula:
C24H32O7
Formula Weight:
432.51
Specification
Relative Density:
1.135 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Schisandrin can be used for antioxidant drug and immune system related drug development.
Library Information
Targets:
Autophagy
Receptors:
Autophagy
Pathways:
Autophagy
Plate Number:
AOCL-4
Plate Location:
f10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 104.04 mM





